The share price of BridgeBio Pharma, Inc. (BBIO) now
What analysts predict: $46.18
52-week High/Low: $36.36 / $6.64
50/200 Day Moving Average:
$26.86 / $21.26
This figure corresponds to the Average Price over the previous 50/200 days.
For BridgeBio Pharma stocks, the 50-day moving average is the support level today.
For BridgeBio Pharma stocks, the 200-day moving average is the support level today.
Are you interested in BridgeBio Pharma, Inc. stocks and want to buy them, or are they already in your portfolio?
If yes, then on this page you will find useful information about the dynamics of the BridgeBio Pharma
stock price in 2023, 2024, 2025, 2026, 2027.
How much will one BridgeBio Pharma share be worth in
2023 - 2027?
When should I take profit in BridgeBio Pharma stock?
When should I record a loss on BridgeBio Pharma stock?
What are analysts' forecasts for BridgeBio Pharma stock?
What is the future of BridgeBio Pharma stock?
We forecast BridgeBio Pharma stock performance using neural networks based on historical data on BridgeBio Pharma stocks.
Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
BridgeBio Pharma stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals.
(Next month, 2023, 2024, 2025, 2026 and 2027)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for BridgeBio Pharma shares. This happens once a day.
Historical and forecast chart of BridgeBio Pharma stock
The chart below shows the historical price of BridgeBio Pharma stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the BridgeBio Pharma stock price can be found in the table below.
Long-term forecasts by years.
BridgeBio Pharma, Inc. is engaged in the discovery, development and supply of various drugs for genetic diseases. The company has a portfolio of 20 development programs that include candidate products from early discovery to late development.
Trending Themes in the Healthcare Sector
BridgeBio Pharma daily forecast for a month
Date
Target
Pes.
Opt.
Vol., %
Dec 05
31.07
30.20
31.55
4.49
Dec 06
31.37
30.47
32.01
5.07
Dec 07
30.74
29.83
31.47
5.49
Dec 08
30.25
29.36
30.97
5.49
Dec 09
30.37
29.98
30.82
2.77
Dec 10
31.46
31.01
32.33
4.24
Dec 11
31.20
30.80
31.85
3.41
Dec 12
31.25
30.75
32.04
4.21
Dec 13
30.63
30.34
30.95
2.02
Dec 14
30.36
29.81
31.15
4.48
Dec 15
29.92
29.31
30.60
4.38
Dec 16
29.59
29.01
29.88
2.98
Dec 17
30.49
29.64
31.10
4.91
Dec 18
31.45
30.82
31.83
3.28
Dec 19
31.39
30.58
31.82
4.06
Dec 20
30.81
30.44
31.55
3.63
Dec 21
31.40
30.82
31.95
3.66
Dec 22
30.91
30.36
31.25
2.90
Dec 23
29.87
29.10
30.45
4.63
Dec 24
29.41
28.81
30.21
4.87
Dec 25
29.47
28.92
30.22
4.49
Dec 26
28.99
28.57
29.42
3.00
Dec 27
29.57
29.04
30.41
4.71
Dec 28
29.45
28.65
29.94
4.53
Dec 29
29.77
29.39
30.42
3.48
Dec 30
30.80
30.22
31.15
3.05
Dec 31
31.35
30.86
32.05
3.83
Jan 01
31.57
30.74
31.89
3.72
Jan 02
30.63
29.93
31.23
4.32
Jan 03
30.26
30.03
30.82
2.65
BridgeBio Pharma Daily Price Targets
BridgeBio Pharma Stock Forecast 12-05-2023.
Forecast target price for 12-05-2023: $31.07. Positive dynamics for BridgeBio Pharma shares will prevail with possible volatility of 4.299%. Pessimistic target level: 30.20 Optimistic target level: 31.55
BridgeBio Pharma Stock Forecast 12-06-2023.
Forecast target price for 12-06-2023: $31.37. Positive dynamics for BridgeBio Pharma shares will prevail with possible volatility of 4.823%. Pessimistic target level: 30.47 Optimistic target level: 32.01
BridgeBio Pharma Stock Forecast 12-07-2023.
Forecast target price for 12-07-2023: $30.74. Negative dynamics for BridgeBio Pharma shares will prevail with possible volatility of 5.205%. Pessimistic target level: 29.83 Optimistic target level: 31.47
BridgeBio Pharma Stock Forecast 12-08-2023.
Forecast target price for 12-08-2023: $30.25. Negative dynamics for BridgeBio Pharma shares will prevail with possible volatility of 5.205%. Pessimistic target level: 29.36 Optimistic target level: 30.97
BridgeBio Pharma Stock Forecast 12-09-2023.
Forecast target price for 12-09-2023: $30.37. Positive dynamics for BridgeBio Pharma shares will prevail with possible volatility of 2.698%. Pessimistic target level: 29.98 Optimistic target level: 30.82
BridgeBio Pharma Stock Forecast 12-10-2023.
Forecast target price for 12-10-2023: $31.46. Positive dynamics for BridgeBio Pharma shares will prevail with possible volatility of 4.068%. Pessimistic target level: 31.01 Optimistic target level: 32.33
Market capitalization of the BridgeBio Pharma, Inc. is the total market value of all issued shares of a company. It is calculated by the formula
multiplying the number of BBIO shares in the company outstanding by the market price of one share.
EBITDA:
-537 753 984 $
EBITDA of BridgeBio Pharma is earnings before interest, income tax and depreciation of assets.
PE Ratio:
None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio:
None
Price/earnings to growth
DPS:
N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY:
N/A
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS:
-3.91
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY:
N/A
Quarterly Revenue Growth YOY:
11.1
Trailing PE:
-
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE:
-
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue:
28.78
Enterprise Value (EV) /Revenue
EV To EBITDA:
-6.16
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding:
173967000
Number of issued ordinary shares
Shares Float:
N/A
Number of freely tradable shares
Shares Short Prior Month:
N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and,
moreover, are not trading signals.
When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market
as a result of using the information contained on the site.
This website uses cookies to ensure you get the best experience on our website